Correction: Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation.

Cao, Yanyan; Sun, Tao; Sun, Bo; Zhang, Guilin; Liu, Jiayun; Liang, Bin; Zheng, Chuansheng; Kan, Xuefeng

Cao, Yanyan; Sun, Tao; Sun, Bo; Zhang, Guilin; Liu, Jiayun; Liang, Bin; Zheng, Chuansheng; Kan, Xuefeng.

Afiliação

Cao Y; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Sun T; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
Sun B; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Zhang G; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
Liu J; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Liang B; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
Zheng C; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Kan X; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.

J Nanobiotechnology ; 21(1): 464, 2023 Dec 04.

Article em En | MEDLINE | ID: mdl-38044458

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google